PDCD1 and neoplasm: In contrast to the CTLA-4 molecule, which regulates the activation of T lymphocytes at an early stage of the immune response, inhibiting their autoreactivity within the lymph nodes, in the case of an immune response involving PD-1 molecules, this inhibition occurs in peripheral tissue or in the tumor microenvironment [9].